BenHirschler
Stories by BenHirschler
Nestle, Unilever, Coke place bids for over $4b GSK India business
The three consumer goods giants are seen as frontrunners for a business that offers a significant footprint in a fast-growing emerging market.
GSK seeks mid-Sept bids for $4b Horlicks unit in India
The main asset on the block in the sale is GSK's 72.5% stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare, which is famous for Horlic
Japan’s Takeda to buy drugmaker Shire in landmark $62b deal
The final deal is approximately 46 percent cash and 54 percent stock, leaving Shire shareholders owning around half of the combined group.
Drug maker Shire rejects $63b Takeda bid as Allergan drops pursuit
Shire said Takeda's proposals significantly undervalued the company's growth prospects and drugs in development.
GSK’s bid in focus as Reckitt pulls out of Pfizer consumer health business auction
Pfizer has been hoping to fetch as much as $20 billion for its consumer health business.
Merck to buy Australian viral immuno-oncology firm Viralytics for $394m
Merck will pay 1.75 Australian dollars per share for the Sydney-based biotech company.
Google’s VC arm, Sequoia China back $27m round in UK’s universal flu vaccine maker
Vaccitech will use the proceeds to fund its vaccine through a two-year clinical trial involving more than 2,000 patients and expand other projects.
Lifescience sector got off to flying start in 2018 with biotech bids worth $11b
This follows a relatively subdued 2017, when total life sciences M&A totalled around $200 billion.
AstraZeneca steps up China push with new drug JV, to partner state-backed PE fund
Dizal Pharma will be owned equally with the Chinese Future Industry Investment Fund.
GSK said to consider sale of UK Horlicks business, hold on to India unit
In Britain, where Horlicks is sold as a bedtime drink, the product has largely fallen out of favour and sales are very limited.
